ISRG Stock Recent News
ISRG LATEST HEADLINES
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Investors are always on the lookout for the next stock split -- for a couple of reasons. These operations that increase the number of shares and reduce the per-share price accordingly often make it easier to invest in a high-flying stock.
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
As earnings season concludes, investors looking for meaningful catalysts to point to as reasons to own specific stocks certainly have plenty to think about.
Intuitive Surgical (ISRG 1.26%)best known for its flagship da Vinci robot, is the global leader in the robotic surgery market. The da Vinci, available in several versions including the latest da Vinci 5, generates billions of dollars of revenue annually, and this performance has helped the company's stock soar over the near term and the long term.
The Investment Committee give you their top stocks to watch for the second half.
Intuitive Surgical has maintained an uptrend in the past six months on the back of robust da Vinci portfolio performance. The stock has also gained during the past month.
Robotics is something that is transforming many industries -- and one of the biggest winners is the area of healthcare. Using robots in minimally invasive surgeries has been shown to decrease chances of complications, shorten hospital stays, and lower mortality rates.
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.